QuidelOrtho Corp (QDEL)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $736.90M
Last updated: Nov 17, 2026 at 4:10 PM ET
QuidelOrtho Corp (QDEL) Statistics
QuidelOrtho (QDEL) has a market cap of $736.90M and an enterprise value of $3.51B. Its net debt of $2.77B equals 376.02% of its market cap. It kept -14.24% of revenue as net income over the last 12 months.
Total Valuation
Enterprise value is 376.02% above the market cap, as debt exceeds cash.
| Market Cap | $736.90M |
|---|---|
| Enterprise Value | $3.51B |
| Latest price (Nov 17, 2026) | $9.87 |
Key Dates
The next earnings report is expected on Feb 9, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 9, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 3, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.3x and 0.4x. Its year-end P/E ranged from 4.9x to 58.6x from 2017 to 2025.
| P/E Ratio | 11.5x |
|---|---|
| Forward P/E | 14.5x |
| P/S Ratio | 0.3x |
| Forward P/S | 0.3x |
| P/B Ratio | 0.4x |
| P/OCF Ratio | 93.3x |
Enterprise Valuation
Counting debt and cash, the company is valued at 10.6x EBITDA.
| EV / Sales | 1.4x |
|---|---|
| EV / EBITDA | 10.6x |
Price Statistics
The stock is down 53.75% over 52 weeks and trades 18.83% below its 50-day average.
| Beta (1Y) | 2.58 |
|---|---|
| 52-Week Change | -53.75% |
| 1-Month Change | -22.65% |
| 3-Month Change | -28.48% |
| 6-Month Change | -13.27% |
| 5-Year Change | -90.02% |
| 10-Year Change | -31.35% |
| Total Return (1Y) | -53.75% |
| Total Return (3Y CAGR) | -46.98% |
| Total Return (5Y CAGR) | -41.57% |
| Return vs SPY (1Y) | -65.18% |
| Max Drawdown (1Y) | -72.10% |
| Max Drawdown (3Y) | -86.92% |
| Sharpe Ratio (1Y) | -0.83 |
| Correlation with SPY (1Y) | 0.38 |
| 50-Day Average | $12.16 |
| 200-Day Average | $15.20 |
| 52-Week Range | $9.92 to $35.58 |
| RSI (14 Days) | 35.2 |
| Average Volume (20 Days) | 2.65M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.36x current liabilities, and total debt is 1.64x shareholder equity.
| Current Ratio | 1.36x |
|---|---|
| Quick Ratio | 0.75x |
| Debt / Equity | 1.64x |
| Debt / EBITDA | 8.99x |
| Interest Coverage | 0.84x |
Returns and Efficiency
Return on invested capital is -2.85% over the last 12 months, against a 5-year average of -1.23%.
| Return on Equity (ROE) | -20.61% |
|---|---|
| Return on Assets (ROA) | -6.39% |
| Return on Invested Capital (ROIC) | -2.85% |
| Return on Capital Employed (ROCE) | -2.86% |
| ROE (5Y Average) | -16.05% |
| ROA (5Y Average) | -3.30% |
| ROIC (5Y Average) | -1.23% |
| Asset Turnover | 0.45x |
| Inventory Turnover | 2.29x |
| Receivables Turnover | 5.68x |
| Cash Conversion Cycle | 162 days |
Scores
QDEL has an Altman Z-Score of 0.25, in the distress zone below 1.81, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 0.25 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $2.59B over the last 12 months is down 4.47% from the 12 months before.
| Revenue | $2.59B |
|---|---|
| Revenue Growth (YoY) | -4.47% |
| Gross Profit | $1.15B |
| Operating Income | -$123.00M |
| Pretax Income | -$336.00M |
| Net Income | -$369.20M |
| EBITDA | $326.90M |
| EBIT | -$134.80M |
| Reported EPS (TTM) | $0.86 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 30.97% of the $5.78B in total assets.
| Cash and Equivalents | $166.40M |
|---|---|
| Total Debt | $2.94B |
| Net Debt | $2.77B |
| Net Debt Per Share | $40.33 |
| Working Capital | $378.90M |
| Shareholder Equity | $1.79B |
| Book Value Per Share | $26.07 |
| Tangible Book Value | -$837.00M |
| Total Assets | $5.78B |
| Total Liabilities | $3.99B |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $125.80M of capital spending, operating cash flow left -$117.90M of free cash flow.
| Operating Cash Flow | $7.90M |
|---|---|
| Capital Expenditures | $125.80M |
| Free Cash Flow | -$117.90M |
| FCF Per Share | -$1.72 |
| Depreciation and Amortization | $461.70M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -4.74%, against a 5-year average of -4.06%.
| Gross Margin | 44.22% |
|---|---|
| Operating Margin | -4.74% |
| Pretax Margin | -12.96% |
| Net Margin | -14.24% |
| EBITDA Margin | 12.61% |
| EBIT Margin | -5.20% |
| FCF Margin | -4.55% |
| Gross Margin (5Y Average) | 55.48% |
| Operating Margin (5Y Average) | -4.06% |
| Net Margin (5Y Average) | -11.45% |
Growth
Revenue fell 5.80% a year over 3 years, and EPS 50.62% a year.
| Revenue Growth (3Y CAGR) | -5.80% |
|---|---|
| Revenue Growth (5Y CAGR) | +10.44% |
| EPS Growth (3Y CAGR) | -50.62% |
| EPS Growth (5Y CAGR) | -36.12% |
| Book Value Per Share Growth (2Y CAGR) | -38.29% |
Dividends and Yields
QDEL does not pay a dividend. Its free cash flow yield is -17.39%.
| Earnings Yield | 8.70% |
|---|---|
| FCF Yield | -17.39% |
| Shareholder Yield | 4.35% |
Peer Position
Against 5 similar companies, QDEL has the 5th highest P/E.
P/E RatioPeer median 23.4x
P/S RatioPeer median 2.6x
ROICPeer median -12.27%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +13.78%
| P/E Ratio | 11.5x vs 23.4x median |
|---|---|
| P/S Ratio | 0.3x vs 2.6x median |
| ROIC | -2.85% vs -12.27% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -4.47% vs +13.78% median |
Analyst Forecast
Consensus estimates put revenue growth at -4.02% and EPS growth at -21.23% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | -4.02% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | -21.23% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About QDEL
What is QDEL's market cap?
QuidelOrtho has a market cap of $736.90M. Its enterprise value, which adds debt and subtracts cash, is $3.51B.
What is QDEL's P/E ratio?
QuidelOrtho has a trailing P/E ratio of 11.5x and a forward P/E of 14.5x.
How many shares of QDEL are outstanding?
QuidelOrtho has 68.70M shares outstanding. The count is up 1.03% from a year earlier.
Does QDEL pay a dividend?
No. QuidelOrtho does not pay a dividend.
How much debt does QDEL have?
QuidelOrtho has $2.94B of total debt and $166.40M of cash and equivalents, a net debt position of $2.77B.
QDEL pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts